Sarah Wall

Sarah Wall's research focuses on blood and bone marrow transplantation (also called hematopoietic cell transplantation) for people with blood cancers such as myelofibrosis, myelodysplastic/myeloproliferative overlap neoplasms, and acute myeloid leukemia. Much of the work examines how to combine transplants with targeted drugs (like ruxolitinib, a JAK inhibitor, and other kinase inhibitors) to improve outcomes and reduce complications such as graft-versus-host disease. She also contributes to clinical practice guidelines and studies on assessing frailty in older patients to guide treatment decisions.

Publication output grew sharply from 2017 to 2020 and has since remained fairly steady at a higher level, averaging about 16 papers per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026